Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

DiaMedica Therapeutics (DMAC) Cash from Investing Activities (2018 - 2019)

Historic Cash from Investing Activities for DiaMedica Therapeutics (DMAC) over the last 2 years, with Q4 2019 value amounting to $1.0 million.

  • DiaMedica Therapeutics' Cash from Investing Activities rose 765384.62% to $1.0 million in Q4 2019 from the same period last year, while for Dec 2019 it was -$3.9 million, marking a year-over-year decrease of 771600.0%. This contributed to the annual value of $8.6 million for FY2024, which is 14680.04% up from last year.
  • Per DiaMedica Therapeutics' latest filing, its Cash from Investing Activities stood at $1.0 million for Q4 2019, which was up 765384.62% from $3.0 million recorded in Q3 2019.
  • In the past 5 years, DiaMedica Therapeutics' Cash from Investing Activities registered a high of $3.0 million during Q2 2019, and its lowest value of -$10.9 million during Q1 2019.